AXSM vs. ARDX
Compare and contrast key facts about Axsome Therapeutics, Inc. (AXSM) and Ardelyx, Inc. (ARDX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AXSM or ARDX.
Correlation
The correlation between AXSM and ARDX is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AXSM vs. ARDX - Performance Comparison
Loading data...
Key characteristics
AXSM:
0.91
ARDX:
-0.61
AXSM:
1.75
ARDX:
-0.54
AXSM:
1.20
ARDX:
0.92
AXSM:
1.29
ARDX:
-0.54
AXSM:
4.03
ARDX:
-1.55
AXSM:
10.58%
ARDX:
31.25%
AXSM:
45.88%
ARDX:
78.88%
AXSM:
-86.65%
ARDX:
-98.45%
AXSM:
-21.38%
ARDX:
-87.66%
Fundamentals
AXSM:
$5.29B
ARDX:
$928.31M
AXSM:
-$5.77
ARDX:
-$0.23
AXSM:
0.00
ARDX:
-0.08
AXSM:
12.25
ARDX:
2.57
AXSM:
99.51
ARDX:
6.37
AXSM:
$432.16M
ARDX:
$361.71M
AXSM:
$395.36M
ARDX:
$307.75M
AXSM:
-$266.14M
ARDX:
-$31.16M
Returns By Period
In the year-to-date period, AXSM achieves a 28.00% return, which is significantly higher than ARDX's -19.92% return.
AXSM
28.00%
3.68%
17.14%
41.49%
50.69%
4.98%
N/A
ARDX
-19.92%
-15.68%
-18.15%
-48.02%
83.86%
-12.92%
-9.51%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AXSM vs. ARDX — Risk-Adjusted Performance Rank
AXSM
ARDX
AXSM vs. ARDX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Ardelyx, Inc. (ARDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
AXSM vs. ARDX - Dividend Comparison
Neither AXSM nor ARDX has paid dividends to shareholders.
Drawdowns
AXSM vs. ARDX - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, smaller than the maximum ARDX drawdown of -98.45%. Use the drawdown chart below to compare losses from any high point for AXSM and ARDX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
AXSM vs. ARDX - Volatility Comparison
The current volatility for Axsome Therapeutics, Inc. (AXSM) is 9.58%, while Ardelyx, Inc. (ARDX) has a volatility of 37.05%. This indicates that AXSM experiences smaller price fluctuations and is considered to be less risky than ARDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
AXSM vs. ARDX - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Ardelyx, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AXSM vs. ARDX - Profitability Comparison
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported a gross profit of 111.67M and revenue of 121.46M. Therefore, the gross margin over that period was 91.9%.
ARDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Ardelyx, Inc. reported a gross profit of 64.15M and revenue of 74.11M. Therefore, the gross margin over that period was 86.6%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported an operating income of -56.98M and revenue of 121.46M, resulting in an operating margin of -46.9%.
ARDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Ardelyx, Inc. reported an operating income of -36.35M and revenue of 74.11M, resulting in an operating margin of -49.0%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Axsome Therapeutics, Inc. reported a net income of -59.41M and revenue of 121.46M, resulting in a net margin of -48.9%.
ARDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Ardelyx, Inc. reported a net income of -41.14M and revenue of 74.11M, resulting in a net margin of -55.5%.